Skip to main content

What the FDA labels say about taking them together

Itraconazole and levomilnacipran

Levomilnacipran's FDA label of April 30, 2024 names itraconazole in its drug interactions section; the itraconazole labels PlainMeds reads (2) do not name levomilnacipran. The levomilnacipran label: “Concomitant use of FETZIMA with strong CYP3A4 inhibitors increases levomilnacipran exposure.”

Check it at the source: the itraconazole FDA label on DailyMed (effective July 13, 2026, Janssen Pharmaceuticals, Inc.); the levomilnacipran FDA label on DailyMed (effective April 30, 2024, Allergan, Inc.).

What does the itraconazole label say about levomilnacipran?

Itraconazole's label (effective July 13, 2026) and its 1 other brand-application label do not name levomilnacipran in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (SPORANOX), Janssen Pharmaceuticals, Inc., effective July 13, 2026 (SPL set a4d555fa-787c-40fb-bb7d-b0d4f7318fd0), via openFDA; the full label on DailyMed

What does the levomilnacipran label say about itraconazole?

Levomilnacipran label, drug interactions

Strong CYP3A4 Inhibitors Clinical Impact: Concomitant use of FETZIMA with strong CYP3A4 inhibitors increases levomilnacipran exposure. Intervention: The dose of FETZIMA should not exceed 80 mg once daily when used with strong CYP3A4 inhibitors [see Dosage and Administration (). Examples: Ketoconazole, itraconazole, clarithromycin

Source: FDA drug label (Fetzima), NDA204168 (Abbvie), as published by Allergan, Inc., effective April 30, 2024 (SPL set f371258d-91b3-4b6a-ac99-434a1964c3af), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Itraconazole generic labelers
0Levomilnacipran generic labelers
ItraconazoleLevomilnacipran
Labeled forFungal infectionsDepression
Boxed warningYesYes
Pharmacy cost (NADAC)$0.910 per capsule 100 mg capsule$17.61 per unit 20-40 mg titration pak
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?